Symbio Announces Phase I Clinical Unit
Symbio LLC, a full service contract research organization, has announced the opening of a new Phase I Clinical Unit in Michigan City, Indiana.
Port Jefferson, NY – Symbio LLC, a full service contract research organization, has announced the opening of a new Phase I Clinical Unit. Since 2002, Symbio has provided services to pharmaceutical, generic and medical device companies that have resulted in many successful clinical trials. Services provided by Symbio include: clinical trial management, biometrics, strategic consulting, product development and topical formulation development. With the addition of the Phase I Unit, a key component to the complete clinical development process, Symbio now has the ability to provide development from Phase I through Phase IV.
In collaboration with Saint Anthony Memorial Hospital in Michigan City, Indiana, the Phase I Unit is a 62 bed capacity facility and is located within the confines of Saint Anthony Memorial Hospital. The hospital provides an entire floor devoted to the conduct of Phase I studies, ensuring the highest quality medical care and safety standards.
Symbio has long-standing, special expertise working with the generic drug industry. The Symbio Phase I Clinical Team is set up to prepare and execute clinical plans to support FDA approval of generic products.
Symbio’s Phase I Unit at Saint Anthony Memorial Hospital is centrally located in northwest Indiana, between the Illinois and Michigan state borders.
Just 45 minutes from downtown Chicago, diverse populations of healthy participants are easily accessible including eight local colleges/universities and technical schools.
For further information contact: Edward Drower, Director of Phase I Clinical Operations
Phone: 219-861-8817, Email: edrower@symbioresearch.com
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
